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We have recently shown that the 39-nontranslated region (39-NTR) of the avirulent Semliki Forest virus A7(74) [SFVA7(74)]
contains a unique sequence of 101 nucleotides and five repetitive nucleotide units whereas the 39-NTR of the neurovirulent
SFV4 has only two repeats. A chimeric virus was constructed by replacing the entire 39-NTR of the SFV4 clone with the A7(74)
39-NTR. The hybrid replicated efficiently in the central nervous system (CNS) of adult Balb/c mice and, similarly to SFV4, led
to high mortality after intraperitoneal inoculation. In contrast, another chimeric virus, CME2, containing the E2 gene of the
avirulent SFVA7(74) virus in the SFV4 clone was recently shown to be avirulent for mice. Several derivatives with single-site
or a constellation of amino acid mutations were constructed. Two single-site E2 mutants, Val37Ile and Asn212Ser, displayed
an attenuated phenotype in mice with mortality reduced from 90 to 48 and 43%, respectively. None of the multiple site
mutants were significantly attenuated. Adult female mice showed a greater resistance to SFV infection than male mice. The
SFV hybrid viruses, CM3NTR and CME2, reached the CNS similarly to the parental viruses, but the single-site E2 mutants
were only sporadically found in the CNS. We conclude that in mice the 39-NTR does not play a significant role in the
pathogenesis of Semliki Forest virus and that specific E2 amino acid mutations reduce the virulence, especially in female
mice. The results additionally suggest that individual amino acid mutations in the E2 glycoprotein affect the efficiency of
migration into the CNS. © 1998 Academic Press
INTRODUCTION
Semliki Forest virus (SFV) belongs to the alphavirus
genus of Togaviridae and infects mosquitoes, birds,
small mammals, and man (Johnston et al., 1996; Mathiot
et al., 1990).
The SFV prototype virion contains a positive-stranded
RNA genome of 11,442 nucleotides encapsidated into an
icosahedric nucleocapsid consisting of multiple copies
of the capsid protein. The nucleocapsid is surrounded by
a lipid bilayer from which the viral spikes, consisting of
three copies of each viral glycoprotein (E3, E2, E1), pro-
trude (Schlesinger et al., 1996). The viral spikes mediate
virus attachment and entry into the cell as well as virus
budding from the infected cells (Tyler et al., 1990; Wahl-
berg et al., 1989, 1992; Zhao et al., 1994).
For several alphaviruses, amino acid mutations in the
E2 glycoprotein have been indicated to be determinants
of virulence by affecting virus binding and entry into
neuronal cells (Davis et al., 1986; Tucker et al., 1991) or
restricting invasion of the CNS (Grieder et al., 1995).
Recently, a Lys162 to Glu change in the E2 glycoprotein
of the SFV4 clone allowed survival of pregnant mice
inoculated intraperitoneally (ip), but killed 11 of 13 adult
mice following intranasal (i.n.) inoculation (Glasgow et
al., 1994).
In addition to the structural proteins, mutation(s) or
deletion(s) in the nontranslated regions (NTR(s)) of the
RNA genome have been shown to alter the virulence,
probably by affecting the replication or translation of the
viral genome (Evans et al., 1985; Kinney et al., 1993; Kuhn
et al., 1992).
We have approached the characterization of SFV vir-
ulence in mice by using the natural avirulent virus isolate
SFVA7(74) (McIntosh et al., 1961) and the virulent SFV4
obtained by transcription of a cDNA clone of the SFV
prototype and transfection of viral RNA into mammalian
cells (Liljestro¨m et al., 1991).
Following ip inoculation of adult Balb/c mice the
SFVA7(74) strain replicates in muscle tissue leading to
plasma viremia (Amor et al., 1996; Fazakerley et al.,
1993). Successively, the virus enters the CNS by infecting
cerebral endothelial cells resulting in blood–brain barrier
damage (Soilu-Ha¨nninen et al., 1994). Within the CNS the
virus replicates primarily in neurons and the infection
remains localized in small perivascular foci, suggesting
that the virus is unable to spread to the adjacent neurons
(Fazakerley et al., 1993). In contrast, the SFV4 clone
(Glasgow et al., 1991), which also replicates in neurons
and initiates the infection as small perivascular foci,
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rapidly enlarges within the CNS resulting in acute en-
cephalitis and the death of the animal (Fazakerley et al.,
1993).
We have recently shown that replacement of seven of
the total of eight mutated amino acids in the E2 glyco-
protein of SFV4 with the corresponding SFVA7(74) resi-
dues caused a marked attenuation of the former virus
(Santagati et al., 1995). Furthermore, analysis of the
SFVA7(74) genome has revealed a unique 39-NTR com-
posed of a unique sequence of 101 nucleotides, imme-
diately downstream of the E1 gene, followed by five
tandem repeats that can potentially regulate RNA repli-
cation and therefore the virulence by alternatively pairing
to a complementary nucleotide sequence at the 59-NTR
of the genome (Santagati et al., 1994).
In this study we analyzed (i) the role of the unique
39-NTR in SFV virulence in mice, (ii) the effect on viru-
lence of specific amino acid substitutions in the E2
glycoprotein of SFV4, and (iii) the sex dependence in the
outcome of SFV infection.
RESULTS
Replacement of the 39-NTR of SFV4 by the equivalent
region of SFVA7(74) preserves a lethal phenotype. The
39-NTR of SFVA7(74) contains a unique sequence of 101
nucleotides followed by five tandemly organized repeats
(Fig. 1A). Each one is potentially capable of forming a
circular RNA by pairing with an inverted complementary
sequence found in the 59-NTR of SFVA7(74) as well as the
59-NTR of SFV4 (Santagati et al., 1994; Tarbatt et al.,
1997). It was therefore of special interest to clarify the
relevance for viral replication of this unique locus. Fe-
male and male adult Balb/c mice were inoculated ip with
106 PFU of the CM3NTR chimera and four mice, two
female and two male, were sacrificed daily.
FIG. 1. (A) Schematic representation of the RNA genome of the recombinant CM3NTR. The enlargements show the A7(74) 39-NTR containing a
unique sequence of 101 nucleotides , five repeats
 
  
 , a short motif n included in each repeat, the homologous region h, and the SFV4 39-NTR
having only two repeats and an homologous region (both marked as above). (B) CM3NTR replication in brain (PFU/g) and in blood (PFU/ml) of adult
Balb/c AnNHsd mice inoculated ip with 106 PFU of virus. Each bar represents an individual mouse (black bar, male; white bar, female). A value of
2 was arbitrarily given to indicate animals with titers under the detection limit. Antibodies were measured by ELISA in the plasma of mice used for
virus titer determination.
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The virus was detectable in the blood during the first 3
days of infection, with the highest titer on day 1 p.i. (.105
PFU/ml). In the brain, CM3NTR reached a titer of 107
PFU/g already on day 2 p.i. and titers of this level, with
the exception of day 4 p.i. (102–104 PFU/g), were found
throughout the following days (Fig. 1B). The recombinant
CM3NTR was frequently found in the brain of the sam-
pled mice except for day 1 and day 4 p.i. where the virus
was detected only in half of the sampled mice (Fig. 1B).
The virus replication in vivo correlated with the degree
of virulence determined in another group of adult mice.
Similarly to SFV4, the CM3NTR was virulent, killing 14 of
20 mice, and the clinical symptoms in the affected mice
resembled those seen in fulminant CNS infection caused
by SFV4 (Table 1).
Single amino acid changes in the E2 glycoprotein
remarkably decrease virulence in adult mice. In vivo
replication of the CME2 virus, a recombinant virus con-
taining the E2 gene of the SFVA7(74) strain in an SFV4
background, has been studied recently in Balb/c mice
(Santagati et al., 1995). Similarly to avirulent SFVA7(74),
CME2 replicates in the brains of adult mice with moder-
ate titers (up to 1.5 3 105 PFU/g) in contrast to the virulent
SFV4 (maximum mean value 1 3 108 PFU/g), suggesting
that the amino acid substitutions in the E2 glycoprotein
are able to affect the virulence (Fig. 2). To assess the
contribution of the individual E2 amino acid substitutions
to SFV pathogenesis, several single, double, and triple
mutants were constructed (Table 2). The effect of two E2
amino acid changes (K104T and K162E) have been pre-
viously investigated by Glasgow et al. (1994) and they
were not further examined in this study (see Discussion).
Following intraperitoneal infection with the E2 mutants
(Table 2), virus was consistently detected in the blood
FIG. 2. Replication of SFV4, SFVA7(74), and CME2 was determined in
({) brain (PFU/g) and in (h) blood (PFU/ml) of adult female Balb/c
AnNHsd mice inoculated ip with 106 PFU of virus. A value of 1 was
given for plotting on a logarithmic scale the 0 values. Antibodies (F)
were measured by ELISA in the plasma of mice used for virus titer
determination. Each point represents the mean of two mice.
TABLE 1
Virulence of SFV Chimera and E2 Mutants in Female and Male
Balb/c AnNHsd Mice Inoculated ip at a Dose of 106 PFU
Virus strain No. dead/no. infected % Mortality
Mean day of
death (6SE)
SFV4 F. 36/44a 81 6.7 (60.4)
M. 23/23 100 5.8 (60.2)
SFVA7(74) F. 0/28b 0 NA
M. 0/31 0 NA
CME2 F. 0/5b 0 NA
M. 0/5 0 NA
CM3NTR F. 10/15 66 5.5 (60.3)
M. 4/5 80 8.5 (61.6)
SFE2-01 F. 5/15b 33 10.0 (62.0)b
M. 7/10 70 6.2 (60.4)
SFE2-02 F. 4/14b 28 5.7 (60.8)
M. 9/16 56 6.6 (60.7)
SFE2-03 F. 8/15a 53 5.3 (60.4)b
M. 15/15 100 5.3 (60.2)
SFE2-04 F. 8/10 80 7.2 (60.7)
M. 9/10 90 5.5 (60.3)
SFE2-05 F. 10/12 83 6.5 (60.5)
M. 10/10 100 5.2 (60.1)
SFE2-06 F. 5/10a 50 6.0 (60.4)
M. 18/20 90 5.5 (60.2)
SFE2-07 F. 9/10 90 6.1 (60.5)
M. 10/10 100 5.7 (60.1)
Note. NA, not applicable; SE, standard error.
a Significantly different compared to SFV4 (P # 0.05) calculated using
Fisher’s exact test for mortality and Student’s t test for day of death.
b Dead female mice significantly differing (P , 0.05) from dead male
mice according to Fisher’s exact test.
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during the first 2 days p.i. (Fig. 3). The titers ranged from
102 to 106 PFU/ml and the lowest values on day 1 were
determined following infection with SFE2-01 (102–104
PFU/ml), whereas SFV4, SFVA7(74), and CME2 ranged
from 103 to 107 PFU/ml (Fig. 2).
In the brain, the E2 mutants, independently of the
degree of virulence (see below), reached titers of 107–108
PFU/g (Fig. 3) similarly to SFV4 (Fig. 2). However, follow-
ing infection with either SFE2-01 or SFE2-02, the two
attenuated mutants (see below), their virus titers in the
brain remained below 106 PFU/g until day 4 p.i. whereas
for the other E2 mutants values exceeding 106 PFU/g
were already detected on day 3 p.i. (Fig. 3).
Generally, E2 mutants were detected in the brain at the
earliest on day 3 p.i. with the exception of SFE2-01,
SFE2-03, and SFE2-05 which were occasionally found on
day 1 and on day 2 p.i. (Fig. 3). However, delayed ap-
pearance of the virus in the brain was also observed
following infection with SFV4 whereas CME2 or
SFVA7(74) were already detected on day 1 p.i. (Fig. 2).
One common characteristic among the single-site E2
mutants SFE2-01, SFE2-02, and SFE2-03 was the spo-
radic occupation of the brain (Fig. 3). To some extent this
was also observed with SFV4 and this might be ascribed
to the glutamic acid to lysine substitution at position 162
of pSP6-SFV4 which arose during construction (Glasgow
et al., 1994). A glutamic acid residue was found instead
at an equivalent position in SFVA7(74) as well as in the
SFV prototype used for the construction of pSP6-SFV4
(Santagati et al., 1995; Garoff et al., 1980).
For mortality studies, mice were inoculated with each
of the E2 mutants as well as with the chimeric CM3NTR
and CME2 and the parental viruses (Table 1). In each
group the clinical symptoms of the affected mice resem-
bled those seen in fulminant CNS infection, although in
mice that had obtained SFE2-01 (V37I) the symptoms
appeared later in the infection (Table 1). The two single-
site E2 mutants, SFE2-01 (V37I) and SFE2-02 (N212S),
were clearly attenuated, causing 48 and 43% mean mor-
tality, respectively, whereas 76% of the infected mice
succumbed following inoculation with the third single-
site mutant SFE2-03 (M215K). All examined combinations
obtained from the single amino acid mutations V37I 1
M215K, N212S 1 M215K, and V37I 1 N212S 1 M215K
displayed a fully virulent phenotype (Table 1).
Immunohistochemical analysis of the CNS. The distri-
bution of the viral antigen in the CNS was studied in
female adult Balb/c mice inoculated ip with 106 PFU of
selected E2 mutants, SFE2-01, SFE2-02, SFE2-03, or
SFE2-04 as well as with the parental and the recombi-
nant viruses.
In each group of mice the CNS distribution of the viral
antigen (Figs. 4 and 5)correlated with the virus titer in the
brain (Figs. 3 and 4). Viral antigen seemed to be mostly
located in cells with neuronal morphology. SFVA7(74)
was frequently found within the brain of all sampled mice
and formed foci of infection, primarily in the perivascular
sites of the cerebellum (Figs. 4A and 4B). In contrast, in
the SFV4-infected mice, the viral antigen was widely
distributed throughout the brain and was strongly
present in neurons (Fig. 4C). Similarly to SFV4, the
CM3NTR was largely found in neurons of the pons and
cerebellum (Figs. 4D and 4E), whereas the CME2 was
focally distributed within the brain (data not shown),
consistent with the virulence and virus titer and similarly
to SFVA7(74).
Interestingly, several mice infected with the single-site
mutants SFE2-01, SFE2-02, and SFE2-03 were viral anti-
gen negative. However, the virus was widely distributed
throughout the brain and spinal cord of the affected mice,
occupying neurons (Figs. 4F and 4G and 5A to 5F). A
possible explanation for this phenomenon could be the
reduced capacity of the virus to migrate to and/or pen-
etrate into the CNS as has been described for Venezu-
elan equine encephalitis virus (Grieder et al., 1995). In
accordance with the degree of virulence, SFE2-04 was
largely distributed through the cortex and thalamus (Figs.
5G and 5H).
Plasma antibody response. As it was not clear whether
the mice lacking viral CNS occupation had developed an
immune response to the virus, plasma antibodies were
measured by ELISA. In each infected group of mice (Figs.
1B, 2, and 3), SFV antibodies started to appear on day
4 p.i., increased during the following days, and declined
after day 8 p.i., as is found in SFE2-02, SFV4 and
SFVA7(74) infection (Figs. 2 and 3). For SFE2-05 as well
as for the CM3NTR chimera, the lack of mice late in the
infection did not allow us to make any conclusions about
the antibody response. However, all infected mice had
developed an SFV antibody response independently of
the detection of virus in the CNS.
Sex-dependent susceptibility to SFV infection. All mice
analyzed originated from the same specific pathogen-
free litters and hence should have a similar immunolog-
TABLE 2
List of SFV E2 Chimera and Mutantsa
Virus strain
E2 amino acid residues
37 104 162 212 215 367 371 389
SFV4 V K K N M V V V
A7(74) I T E S K A A A
CME2 I T E S K A A —
SFE2-01 I — — — — — — —
SFE2-02 — — — S — — — —
SFE2-03 — — — — K — — —
SFE2-04 I — — S — — — —
SFE2-05 I — — — K — — —
SFE2-06 — — — S K — — —
SFE2-07 I — — S K — — —
a Only amino acids differing from the parental SFV4 are shown.
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FIG. 3. Following ip inoculation of adult Balb/c AnNHsd mice with 106 PFU of each E2 mutants, the viral titer in brain (PFU/g) and blood (PFU/ml)
has been determined. Each bar (black, male; white, female) represents the viral titer determined in an individual mouse. A value of 2 was arbitrarily
given to indicate animals with titers under the detection limit. Antibodies were measured by ELISA in the plasma of mice used for virus titer
determination.
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FIG. 4. Immunoperoxidase staining of brains and spinal cords of SFV-infected mice. (A) A few antigen-positive foci of SFVA7(74) are seen in the
cerebellum (c), but not in pons (p). (B) Higher magnification of the area in A marked with an open arrow showing the infected neurons. (C) Strong
deposits of viral antigen are seen in the Purkinje cells (curved arrow) of SFV4-infected mouse. (D) CM3NTR is widely seen in pons (p) but is present
in the cerebellum (c) as scattered foci of infection. (E) Higher magnification of D (open arrow) showing the infected Purkinje neurons (curved arrows)
and granule cells (arrow). (F) Numerous foci of infection (arrows) are seen in the spinal cord of SFE2-02 infected mouse. (G) Higher magnification
of F (open arrow) showing the infected neurons (arrows). Magnifications: the scale bar shown in A corresponds to 0.6, 0.5, and 0.3 mm in A, D, and
F, respectively; 0.060 and 0.025 mm in B and G; and 0.040 mm in C and E.
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FIG. 5. Immunoperoxidase staining of CNS tissue of Balb/c AnNHsd mice infected with SFV E2 mutants. (A) Numerous foci of infection (arrows)
are seen in both cortex (co) and thalamus (t) of a SFE2-01 infected mouse. (B) Greater magnification of the area marked with an open arrow in A
showing positive staining of the neuronal cell body and dendritic projections (star). (E) SFE2-01 infection is widely spread also in the cerebellum. (C)
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ical history. Generally, female mice appeared more re-
sistant to SFV infection (Table 1) and, especially in infec-
tion with SFV4, SFE2-03, and SFE2-06, the difference in
the susceptibility between male and female was statis-
tically significant by Fisher’s exact test (Table 1).
DISCUSSION
Using the avirulent SFVA7(74) and virulent SFV4
strains, we have mapped genomic loci governing the
Semliki Forest virus virulence. In alphaviruses, cycliza-
tion of the RNA genome is considered to be important for
RNA replication because it allows the RNA replicase to
simultaneously interact with replication elements located
at the 59- and 39-ends of the genome (Frey et al., 1979; Ou
et al., 1983). Therefore, the five tandem repeats found in
the 39-NTR of SFVA7(74), but not in the prototype strain,
make this region a good candidate to influence viral
replication by allowing the formation of alternative circu-
lar panhandle structures (Ou et al., 1983). However, the
high virulence and the wide occupation of the CNS
displayed by the CM3NTR chimera suggest that either
alternative RNA pairing sites are allowed or that one
specific functional repeat is energetically most econom-
ical for the RNA secondary structure and is therefore
favored, excluding at the same time interference by the
other repeats. Nevertheless, the unique 39-NTR of
SFVA7(74) might still influence viral replication in hosts
other than mammals, for example, insects. It is likely that
SFV, performing its viral life cycle in nature and alternat-
ing between invertebrate and vertebrate hosts, requires
a genomic region with high plasticity which, by interact-
ing with a variety of host proteins, regulates virus repli-
cation thus ensuring its maintenance (Kuhn et al., 1990,
1992).
We showed that, in contrast to CM3NTR, recombinant
CME2 was avirulent in adult mice (Santagati et al., 1995)
and resembled the parental SFVA7(74) therefore indicat-
ing that the E2 domain is critical for SFV pathogenesis.
The restriction of SFVA7(74) replication in adult neurons
is due to the inability of the virus to form intact virions
(Fazakerley et al., 1993). Whether the restricted replica-
tion of CME2 in adult mouse CNS resides in virion
formation or is due to defects at other stages of the viral
replication involving the E2 glycoprotein, such as virus
entry (Wahlberg et al., 1989) or RNA synthesis (Dropulic
et al., 1997), cannot be concluded from the data pre-
sented here. Further studies are in progress. However, it
is likely that the restricted replication of CME2 in the
CNS is dependent on the spike conformation, as sug-
gested by our recent observation that a recombinant
SFV4 expressing the entire structural region of
SFVA7(74), was fully virulent in adult mice (Tuittila et al.,
unpublished data).
The CME2 chimera differs from SFV4 by 7 amino acid
residues in the E2 glycoprotein (Santagati et al., 1995),
two of which have been analyzed previously by Glasgow
et al. (1994). They showed that a Lys to Glu change at E2
position 162 (SFV4 mut8902 a/g) abolished the virulence
in pregnant mice after intraperitoneal inoculation but
retained the virulence in adult mice when given intrana-
sally, whereas a Lys to Thr change at E2 position 104
(SFV4 mut8729 a/c) did not affect the virulence in either
adult or pregnant mice when administered by the intra-
nasal or intraperitoneal route, respectively (Glasgow et
al., 1994). The avirulence in pregnant mice of the SFV4
mut8902 which, similarly to SFVA7(74), infected and
caused death of the fetuses, might, however, be due to
pregnancy-associated immune potentiation as de-
scribed previously for SFVA7 (Milner et al., 1984) and may
not reflect true attenuation of the virus. The significance
of this mutation remains obscure as differences in the
virulence due to different routes of infection cannot be
excluded (Glasgow et al., 1991).
We observed that female mice are generally more
resistant than male mice to SFV infection. Differences in
susceptibility to virus or other pathogens between the
genders have been observed both in animal models,
including Leishmania (Satoskar et al., 1995), encephalo-
myocarditis virus (Gaines et al., 1986), and coxackievirus
(Wong et al., 1977) as well as in human picornavirus
infections (Nelson et al., 1979; Woodruff et al., 1980).
Generally the differences have been associated with sex
hormones (Friedman et al., 1972; Pozzetto et al., 1985),
although an increased early production of interferons
has also been found to confer resistance to encephalo-
myocarditis virus in female mice (Pozzetto et al., 1985).
In this report we have analyzed, for the first time, the
role in SFV virulence of the individual E2 amino acids by
which the avirulent CME2 differs from the virulent SFV4
strain in the ectodomain region. The finding that both
SFE2-01 (V37I) and SFE2-02 (N212S) are widely spread
within the CNS of mice suggests that, rather than being
deficient in the replication, like SFVA7(74), these mutants
are restricted in invading the CNS, thus resulting in
apparent avirulence, as was also reported for specific E2
mutants of Venezuelan equine encephalitis virus
Greater magnification of E (open arrow) showing deposits of viral antigen in granule and Purkinje cells with affected dendrites (small arrow). (D)
Strong SFE2-03 infection of cerebellum (c) and pons (p). (F) Greater magnification of D (open arrow) showing infected Purkinje cells (curved arrow)
and their dendritic processes. (G) Several foci of infection are seen following inoculation with SFE2-04 both in cortex (co) and thalamus (t). (H) Higher
magnification of G (open arrow) showing antigen-positive neurons. Magnifications: the scale bar in A represents 0.6 mm in A and D; 0.060 mm in B
and F; 0.040 mm in C and H; 0.150 mm in E; and 0.5 mm in Figure G.
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(Grieder et al., 1995). One possible mechanism would be
that SFE2-01 and SFE2-02, by displaying different struc-
ture and/or kinetics of replication in the periphery com-
pared to the other E2 mutants, induce the production of
antiviral cytokines such as interferons that limit virus
growth and spread (Trgovcich et al., 1996). Alternatively,
the sporadic recovery from the CNS of the single-site E2
mutants might be explained by an impaired ability to
invade the CNS due to a decreased potency in infection
of endothelial cells of the blood–brain barrier (Soilu-
Ha¨nninen et al., 1994). In contrast, the infrequent recov-
ery from the brain of the third single-site mutant suggests
that it displays high virulence in mice and that this
mutant exerts alternative lethal mechanism(s), for exam-
ple, by infecting other vital organs (Amor et al., 1996).
MATERIALS AND METHODS
Cells, virus strains, and mutants. For growth of SFV,
MBA-13, a transformed mouse brain cell line previously
established in this laboratory, was cultured in MEM sup-
plemented with 5% fetal calf serum and 10 mg/ml of
gentamicin. Baby hamster kidney cells (BHK-21), main-
tained in BHK medium containing 5% fetal calf serum, 5%
tryptose phosphate broth, and 10 mg/ml of gentamicin,
were used in all RNA transfections.
The parental SFVA7(74) strain was obtained from Dr.
H. E. Webb (London) and derived from the original mos-
quitoe-isolated AR 2066 strain after seven passages in
neonatal mouse brain and two plaque purifications
(Bradish et al., 1971). In our laboratory the virus was
plaque purified three times in MBA-13 cells and pas-
saged five times in the same cell line. The SFV4 and the
CME2 recombinant viruses were obtained as previously
described (Santagati et al., 1995).
Construction of CM3NTR chimera. The construction of
the chimeric pCM3NTR plasmid is schematically illus-
trated in Fig. 6. To assemble the entire A7(74) 39-NTR
cDNA into pSP6-SFV4 various subcloning steps were
FIG. 6. Schematic illustration of the construction of the chimeric pCM3NTR plasmid. The gray arches indicate the cDNA derived from SFV4 and
the white arches represent the region derived from A7(74). The nucleotide positions are given from the start of the SFVA7 sequence (Tarbatt et al.,
1997). The restriction enzymes used in each cloning step are given in bold. For details see Materials and Methods.
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required and were made according to standard tech-
niques (Sambrook et al., 1989). Briefly, two fragments
derived from K64 and CL9 clones (Santagati et al., 1994)
were joined together into NdeI/EcoRI-digested pUC19 to
generate the intermediate pNTR plasmid containing the
entire A7(74) 39-NTR. The poly(A), derived from pSP6-
SFV4, was then linked to the A7(74) 39-NTR through
different intermediate vectors to give the final pCM3NTR.
The fidelity of the expression plasmid was shown by
restriction enzyme and sequence analyses as well as by
hybridization using an oligonucleotide specific for the
39-NTR unique sequence of 101 nucleotides of SFVA7(74)
(Santagati et al., 1994).
Site-directed mutagenesis. Site-directed mutagenesis
was performed according to the procedure of Kunkel et
al. (1987) with slight modifications. Briefly, relevant frag-
ments of pSP6-SFV4 were subcloned into bacteriophage
M13 vector and successively used to transfect a dut2
ung2 Escherichia coli strain in the presence of uridine.
The uridinilated single-stranded DNA were used as tem-
plate for the synthesis of the mutagenized complemen-
tary strand by appropriate phosphorylated oligonucleo-
tides. The heteroduplex DNA was transformed into E.
coli XL1 Blue. Finally, the mutated DNA fragments were
engineered into pSP6-SFV4 to generate the final expres-
sion vectors listed in Table 2.
The mutations were confirmed by sequence analysis
of the mutated region in the final expression vector as
well as of the corresponding PCR fragments obtained
from purified viral RNA.
Transcription and transfection. Infectious RNA tran-
scripts were obtained as previously described (Santagati
et al., 1995) except for pCM3NTR plasmid that was lin-
earized with SpeI restriction enzyme, extracted with phe-
nol–chloroform and ethanol precipitated prior to tran-
scription. The RNA transcripts were transfected into
BHK-21 cells and the supernatant containing viruses was
used to infect MBA-13 cells growing in roller bottles
(Santagati et al., 1995). The stocks generally contained
108–109 PFU/ml.
Inoculation of Balb/c mice with SFV viruses. Four to
six-week-old female and male Balb/c AnNHsd mice were
inoculated ip with 106 PFU of each recombinant virus in
100 ml of phosphate-buffered saline (PBS). Mice were
observed daily for a period of 20 days to determine the
percentage of mortality and the mean day of death.
Fisher’s exact test and Student’s t test were employed to
evaluate respectively the statistical differences in the
mortality and in the mean day of death between the SFV
recombinant viruses and SFV4 virus.
For virus replication in vivo, 40 mice (20 male and 20
female) were inoculated with each recombinant virus as
described above. Four mice, 2 male and 2 female, were
sacrificed daily. Similarly, another group of 20 female
mice was inoculated with SFV4, SFVA7(74), and CME2,
respectively. Brain and plasma samples were treated as
described in Santagati et al. (1995). Virus infectivity was
determined by plaque formation assay in MBA-13 cells.
Antibody detection. SFV-specific antibodies were de-
tected in the plasma of mice analyzed for virus titer (see
above) by an enzyme-linked immunosorbent assay
(ELISA). The SFVA7(74) virus was used as antigen (0.5
mg/well) to coat polystyrene microstrips (Labsystems,
Finland). Plasma samples were diluted 1/400 in PBS
containing 5% pig serum and 0.5% Tween 20 and tested
in duplicate. The secondary antibodies were conjugated
with horseradish peroxidase and were specific for
mouse immunoglobulins (Dakopatts, Denmark). The sub-
strate was ortho-phenylenediamine (Ken-En-Tec, Copen-
hagen). The reaction was stopped by adding 1 M NaOH
and the absorbance was read at 490 nm. Mouse anti-
SFV and PBS-inoculated mice plasma were always in-
cluded as positive and negative controls, respectively.
Preparation of viral antigen for ELISA. MBA-13 cells
infected with SFVA7(74) were harvested when 80–90% of
them showed a cytopathic effect. The cells were pelleted
by centrifugation at 10,000 rpm for 30 min in a Sorvall
GSA rotor at 14°C. The pellet was suspended in PBS,
frozen and thawed five times, and successively homog-
enized with 20 strokes in a Dounce homogenizer. The
cellular debris was removed by centrifugation at 1000 g
for 10 min at 14°C and the virus was then pelleted from
the supernatant by centrifugation at 26,000 rpm for 30
min at 14°C in an SW41 rotor. The pelleted virus was
resuspended in PBS. The amount of viral protein was
determined by the Bradford method (Bradford et al.,
1976).
Immunohistochemistry of the CNS. To study the dis-
tribution of viral antigen in the CNS of infected mice,
adult female Balb/c AnNHsd mice were inoculated ip
with 106 of the parental SFV4 or SFVA7(74) viruses or
the SFV recombinant viruses CME2, CM3NTR, SFE2-
01, SFE2-02, SFE2-03, and SFE2-04. On days 4 to 6
three mice per group were anesthetized with CO2 and
perfused via the left ventricle with 10% neutral phos-
phate-buffered formalin (NPBF). Brains and spinal
cords were removed, fixed in 10% NPBF for at least
24 h, and embedded in paraffin. Deparaffinized sec-
tions of 4 mm thickness were stained for SFV antigens
using a polyclonal rabbit anti-SFVA7(74) antibody and
the avidin–biotin–peroxidase detection method (Vec-
tastain ABC kit, Vector Laboratories). The SFV-specific
antibody was produced in rabbit immunized with pu-
rified inactivated SFVA7(74) virus. Appropriate antigen-
negative controls were obtained from mice inoculated
with PBS, while staining-negative controls were pro-
vided by processing SFV4-positive samples but with
the omission of primary antibody.
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